WHAT WE OFFER
The most versatile and cost-effective molecular diagnostics solution for labs
Automated
Utilizing liquid-handling robots, throughput requirements are efficiently addressed with minimal user intervention. This boosts productivity while reducing the necessity for extensive training.
Frictionless
No dedicated equipment needs to be bought.
Test data is directly transmitted to the Laboratory Information System.
IVDR compliant
We actively support our customers from deployment to validation of the testing methodology and provide all necessary documentation and SOPs to meet IVDR requirements.
Cost-effective
Our approach significantly reduces the cost of testing when compared to traditional qPCR-based methods leading to immediate cost savings.
OUR TEST PANELS
Comprehensive molecular diagnostic test panels to deliver clinically actionable results
Gastroenteritis
Panel comprises 4 parasitic, 12 bacterial and 6 viral pathogens.
Pharmacogenomics
Gene panels grouped per drug class following CPIC recommendations.
Urinary tract infections
Panel of bacterial and fungal pathogens.
Respiratory tract infections
Panel comprises 32 viral, 11 bacterial and 1 fungal pathogens.
Sexually transmitted infections
Panel comprises 7 bacterial pathogens.
Gut health
Panels to link gut composition to gut-related conditions.
OUR APPROACH
One workflow, endless possibilities
Our versatile workflow accommodates a wide range of sample types, including feces, (nano)pharyngeal swabs, blood, and urine. It consists of three key steps: nucleic acid extraction, target enrichment, and nanopore-based sequencing. Our workflow is also designed to integrate seamlessly with existing extraction techniques, ensuring smooth and efficient implementation.
Our workflow and test panels are currently only available under a license agreement and are not sold under the CE-IVD label. For more information on licensing terms, please contact us.
ABOUT US
Unlocking the power of omics technologies
Impact Omics was founded in 2022 with a clear mission: to make omics-based diagnostics accessible and affordable for routine clinical use.
In a world filled with data and healthcare technologies, we believe it’s time to move beyond traditional empirical data for treatment decisions.
Our focus is on empowering primary care physicians to help them uncover the root causes of complex syndromic infectious diseases and tailor drug treatments to the individual patient's genetic markup. We do so by developing a range of tests and making them available through strategic partnerships with clinical and microbiology labs.
GET IN TOUCH
Let’s collaborate
Discover how we can increase your profitability for molecular diagnostic testing and offer your physicians the most comprehensive disease insights.
Let us help you elevate your diagnostic capabilities today and reach out to us.